Intraductal carcinoma in situ of the right breast is a non-invasive breast cancer characterized by the proliferation of malignant cells within the ducts of the breast tissue. This condition is clinically significant as it can progress to invasive breast cancer if left untreated. The ICD-10 Code D05.11 facilitates accurate diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can effectively track and manage this condition.
ICD-10 Code D05.11 specifically denotes intraductal carcinoma in situ of the right breast, indicating the presence of abnormal cells confined to the ducts without invasion into surrounding breast tissue. This code is used in clinical documentation and billing when diagnosing patients with this condition, ensuring appropriate treatment and follow-up care.
Intraductal carcinoma in situ of the right breast is a localized form of breast cancer that arises from the epithelial cells lining the ducts. It is crucial to identify and treat this condition promptly to prevent progression to invasive cancer. Regular screening and monitoring are essential for early detection.
ICD-10 Code D05.11 is utilized in SOAP notes to document the diagnosis of intraductal carcinoma in situ of the right breast. It plays a vital role in capturing patient symptoms, assessment findings, and treatment plans, ensuring comprehensive care in both acute and chronic settings.
In SOAP notes, ICD-10 Code D05.11 connects subjective patient reports and objective clinical findings to a formal diagnosis of intraductal carcinoma in situ of the right breast. This code is essential for continuity of care, supporting accurate billing, and meeting EHR documentation standards.
Intraductal carcinoma in situ of the right breast requires timely intervention to prevent progression to invasive cancer. Treatment options may include surgical excision and radiation therapy.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code D05.11 is critical in medical billing, particularly in hospital and outpatient settings for patients diagnosed with intraductal carcinoma in situ of the right breast.
| CPT Code | Description |
|---|---|
| 19301 | Mastectomy, partial (segmental resection) for breast cancer. |
| 19285 | Placement of a breast localization device. |
| 77063 | Breast MRI for evaluation of breast cancer. |
Common Questions About Using ICD-10 Code D05.11 for Intraductal carcinoma in situ of right breast
What are the treatment options for intraductal carcinoma in situ?
Treatment options typically include surgical excision, possibly followed by radiation therapy. The choice of treatment depends on the individual patient's risk factors and preferences.
How is intraductal carcinoma in situ diagnosed?
Diagnosis is usually made through imaging studies such as mammography and confirmed by biopsy, which reveals abnormal cells within the ducts.
Is intraductal carcinoma in situ considered cancer?
Yes, intraductal carcinoma in situ is classified as a non-invasive breast cancer. While it does not invade surrounding tissues, it has the potential to progress to invasive cancer if untreated.
What is the prognosis for patients with intraductal carcinoma in situ?
The prognosis is generally favorable, especially with early detection and appropriate treatment. Regular follow-up is essential to monitor for any signs of progression.
Clinical Notes
SOAP notes
DAP notes
AI medical notes